Related by context. All words. (Click for frequent words.) 68 Samir Devani 54 Sam Fazeli 54 Paul Cuddon 53 Gbola Amusa 53 Kevin Scotcher 53 Navid Malik 52 Carl Seiden 50 Karl Heinz Koch 50 Geoff Meacham 50 Dominic Valder 50 Joshua Schimmer 49 Jeffrey Holford 49 analyst Navid Malik 49 Jon Lecroy 49 Andreas Theisen 48 WestLB Panmure 48 analyst Jami Rubin 48 analyst Cory Kasimov 48 Diggle 48 Chris Shibutani 47 Olav Zilian 47 Bert Hazlett 47 Youssef Ziai 47 Manoj Garg 47 Jami Rubin 47 Kenji Masuzoe 47 analyst Bruce Nudell 47 Anne Critchlow 46 Jason Kantor 46 analyst Jonathan Aschoff 46 Nicola Mallard 46 Green Networks TrueDLP 46 Geoffrey Porges 46 Ambrian Partners 46 analyst Geoffrey Meacham 46 analyst Yaron Werber 46 Deven Choksey KR Choksey 46 Geoffrey Meacham 46 Katharine Wynne 46 Shire LSE SHP 46 Jim Reddoch 46 Yaron Werber 46 Christian Koefoed Nielsen 46 analyst Jaap Meijer 46 Sav Neophytou 45 Trevor Polischuk 45 DVC Da Vinci 45 Jason Gurda 45 Savvas Neophytou 45 analyst Youssef Ziai 45 Mike Trippitt analyst 45 Roopesh Patel 45 analyst Glenn Novarro 45 Jason Kolbert 45 Gerry Hennigan 45 AstraZeneca Plc AZN LN 45 Civil Procedure Sec 45 analyst Tero Weckroth 45 Steven Harr 45 AstraZeneca AZN.L Quote Profile 45 Gert Zonneveld analyst 45 analyst Simon Toyne 45 Bret Holley 44 Philip Dorgan 44 Ceftin 44 Bruce Cranna 44 analyst Sanjay Vidyarthi 44 Eric Ende 44 Carsten Kunold 44 strategist Anais Faraj 44 Michael Blogg 44 Julian Tolley 44 analyst Jim Reddoch 44 Simon Toyne 44 Sebastien Jantet 44 Ronny Gal 44 Roman Cizdyn 44 Shaojing Tong 44 Ulrich Huwald 44 Mike Lenhoff strategist 44 analyst Mark Schoenebaum 44 analyst Chad Friess 44 Ken Cacciatore 44 Andrew Gollan 44 Jon LeCroy 44 Martin Deboo 44 Cracking Da Vinci 44 analyst Gert Zonneveld 44 analyst Gbola Amusa 44 analyst Alexander Peterc 44 Lupuzor 43 brokerage Helvea 43 Gudme Raaschou 43 Alexandra Hauber 43 analyst George Grofik 43 approvability 43 Dr. Jim Birchenough 43 Andrew Nussey 43 analyst Maarten Altena 43 Birgit Kulhoff 43 Cambridge Antibody 43 Geoff Allum 43 Alizyme 43 Ranjit Kapadia 43 Roger Cursley strategist 43 Conduct CoC 43 Dirk Peeters 43 Oxford BioMedica 43 reaffirmed Outperform rating 43 Andrew Kasoulis 43 Mike Trippitt 43 ABPI 43 Hargreaves Landsdown 43 Chris Alliott 43 Jonathan Imlah 43 GW Pharma 43 analyst Jim Birchenough 43 Mike Prew 43 Evolution Beeson Gregory 43 analyst Harm Meijer 43 Daljeet Kohli head 43 George Grofik 43 Teva Ivax 43 Antoine Leurent 43 Pharmas 42 Annabel Samimy 42 Drugmakers AstraZeneca 42 Ivailo Vesselinov 42 Karl Heinz Scheunemann 42 Udo Becker 42 Siddy Jobe 42 Moussatos 42 analyst Martin Deboo 42 economist Rainer Guntermann 42 Steve Liechti 42 Broker Investec 42 Rolf Elgeti strategist 42 Nomura 42 Cipla Ranbaxy 42 Roche Mircera 42 Pharma cos 42 Scott Geels 42 Claude Camire 42 Full Tilt Referral 42 Charles Kernot 42 Oxford Biomedica 42 Geoff Porges 42 Mark Schoenebaum 42 Richard Menzies Gow 42 analyst Wim Hoste 42 Finsbury Worldwide 42 Alexander Groschke 42 Finncap 42 analyst Hiroshi Kamide 42 Richard Slape 42 SkyePharma Plc SKP LN 42 AstraZeneca AZN.L 42 analyst Leon Esterhuizen 42 Akhtar Samad 42 Surajit Pal 42 Glaxo Advair 42 David Jeary 42 Reni Benjamin 42 Broker Bridgewell 42 Jonathan Groocock 42 Jim Birchenough 42 Glaxo 42 AstraZeneca AZN.L 行情 42 Merck Finck analyst 42 Nick Batram 42 Viwat strategist 42 Schoenebaum 42 analyst Angelos Anastasiou 42 Merck MRK.N 42 Salix Pharma 42 Yoshikiyo Shimamine chief 42 Protherics PLC 42 analyst Alexandra Hauber 41 Kevin Lapwood 41 Koen De Leus 41 analyst Reto Huenerwadel 41 Clive Forestier Walker 41 Herman Saftlas 41 Brock Salier 41 Seroquel quetiapine fumarate 41 Bryan Garnier 41 Marchel Alexandrovich 41 analyst Maged Shenouda 41 Dr. Yaron Werber 41 GlaxoSmithKline LSE 41 Helvea 41 Sandoz generic 41 Edward Tenthoff 41 Transkaryotic Therapies TKTX 41 Sanjay Vidyarthi 41 Hiroshi Kamide 41 Joel Sendek 41 Lucian Cook 41 Schering SHR 41 analyst Sapna Srivastava 41 Partnering Agreements 41 analyst Kian Abouhossein 41 Dolat Capital Market 41 Morten Singleton 41 Phil Skolnick 41 Evolutec 41 Sebastian Orsi 41 Shuji Shirota economist 41 Lakis Athanasiou 41 generic Lotrel 41 Prostrakan 41 Jason Napodano 41 GlaxoSmithKline Imitrex 41 Ton Gietman 41 Harm Meijer 41 economist Zach Pandl 41 Barrie Cornes 41 Nick Spoliar 41 Shire SHP.L Quote Profile 41 Liam Igoe 41 Affymax AFFY 41 das folgende Feld 41 Lukas Daalder 41 Richard Staite 41 Vpriv 41 Williams de Broe 41 analyst Charles Kernot 41 Randall Stanicky 41 Nick Bubb retail 41 Andrew Vaino 41 Mark Ebbinghaus 41 Nominated Advisor 41 Skyepharma 41 LSE AZN 41 Claude Zehnder 41 analyst Kirk Materne 41 Astellas Pharma #.T 41 Amylin Eli Lilly 41 Fund GROWTH ISIN 41 Marco Mak 41 Philip Isherwood 41 analyst Andrew Goodsall 41 Nigel Parson 41 Pierre Boucheny 41 Celltech 41 Jonathan Hykawy 41 David Molowa 41 Pantginis 41 Exane BNP 40 Alan Webborn 40 Mark Monane 40 Dr. Joshua Schimmer 40 analyst Bruce Cranna 40 Jonathan Groocock analyst 40 Jochen Rothenbacher 40 Redburn Partners 40 Eoin Fahy chief 40 analyst Morten Singleton 40 Amit Kara 40 analyst Julian Easthope 40 economist Reto Huenerwadel 40 Michael Leuchten 40 De Broe 40 Martin Mabbutt 40 Funtleyder 40 Georg Marti 40 immuno suppressant 40 Julian Heslop 40 Shire SHP.L 40 Carla Antunes da Silva 40 strategist Mike Lenhoff 40 Danny van Doesburg 40 Lavan Gopaul 40 Alessandro Migliorini 40 Singulair asthma 40 Atsushi Seki 40 Arbitration Procedure 40 Civil Procedure § 40 Cormac Leech 40 Angus McPhail 40 breast cancer pill Tykerb 40 GlaxoSmithKline plc 40 Arjan van Veen 40 economist Laurent Bilke 40 Mike Krensavage 40 Equity YIELD ISIN 40 Allan Monks 40 Monane 40 Asenapine 40 Rainer Guntermann 40 Vertex telaprevir 40 AstraZeneca Plc AZN.L 40 Hitesh Agrawal head 40 Harald Liberge Dondoux 40 MedImmune nasal spray 40 Prepandrix 40 Robin Bhar analyst 40 Aceon 40 analyst Ken Trbovich 40 Dr. Debra Birnkrant 40 Joseph Pantginis 40 GlaxosmithKline 40 Oliver Gilvarry 40 MNC pharma 40 Bruce Nudell 40 Ricky Goldwasser 40 Astrazeneca 40 Helena Schwenk 40 BIOTECH STOCKS 40 Trippitt 40 Buy Cheapest Generic 40 Nicox 40 EPT Disclosure 40 analyst Simos Simeonidis 40 Tejas Doshi head 40 EiRx Therapeutics 40 analyst Syd Vianello 40 Pulte Homes Presentation 40 Dr. Gail Cawkwell 40 Geoff Ruddell 40 biosimilar medicines 40 Harit Shah 40 Julian Easthope 40 Badly Broken 40 Cazenove downgraded 40 Altana AAA 40 Martin Possienke 40 Sumit Malhotra 40 Jonathan Aschoff 40 Shire SHPGY 40 Yasmin contraceptive 40 Broker Roundup 40 analyst Phillip Nalbone 40 brokerage Numis 40 LSE GSK 40 analyst Glenn Reicin 40 Norihiro Fujito 40 antidepressant Cymbalta erectile dysfunction 40 WBB Securities LLC 40 Jan De Kerpel 40 Charles DiBona 40 Avastin Herceptin 40 Sena Lund 40 Dave Shove 40 Kosin Sripaiboon 40 George Vasic 40 Amgen anemia 40 Elisabeth Afseth 40 analyst Grant Saligari 40 Michael Krensavage 40 spokesman Tony Plohoros 40 maker Barr Pharmaceuticals 40 Cory Kasimov 40 Christian Weiz 40 Wyeth WYE.N Quote Profile 40 Argatroban 40 analyst Konrad Becker 40 BNP Exane Paribas 40 Deepak Lalwani director 40 Vectura Group 40 Bernard Hanssens 39 Panagiotis Spiliopoulos 39 CSL CSL 39 Nick Bertolotti 39 Guy Hallwright 39 Ipca Labs 39 SXDP 39 Arena Pharmaceuticals ARNA 39 Thomas Nagtegaal 39 analyst Seamus Fernandez 39 Apurva Shah head 39 Arrow Therapeutics 39 Leerink Swan 39 Merck boceprevir 39 Mahesh Sawant 39 ImmuPharma 39 Alex DeGroote 39 outlicensed 39 Criminal Procedure CMK 39 Recentin 39 Tubby Goodwin 39 Robin Chhabra 39 Ark Therapeutics 39 Casodex bicalutamide 39 Elan Biogen 39 Ivan Lathouders 39 sees FY pretax 39 Dechra 39 Merck nyse MRK 39 Helvea analyst Olav Zilian 39 Westhall Capital 39 Anais Faraj strategist 39 Maher Yaghi 39 AstraZeneca AZN 39 Navdeep Jaikaria 39 Tatsuo Yoshida auto 39 Federal Regulations CFR 39 Yasuo Ueki market 39 Shahina Mukadam 39 Wyn Ellis 39 Gerald Khoo 39 UBS analyst Gbola 39 GlaxoSmithKline GSK.L 39 generic omeprazole 39 KBC Securities 39 Animal Efficacy 39 Gilead GILD 39 GlaxoSmithKline GSK.L Quote Profile 39 strategist Graham Secker 39 Deepak Jasani head 39 GSK 39 Damien Conover 39 Philipp Haessler 39 analyst Glyn Lawcock 39 Paul Mansky 39 Thrombogenics 39 Paul Wuh 39 Jeremy Sussman 39 Eisai Co 39 Vectura 39 Marco Valli economist 39 Ajay Parmar head 39 Broker snap 39 Procrit Eprex 39 Wellbutrin SR 39 Mamoun Tazi 39 Momenta Pharmaceuticals Inc 39 Cannacord 39 Marek Juras 39 analyst Mike Trippitt 39 Matthew McEachran 39 analyst Mario Mendonca 39 analyst Jeffrey Zekauskas 39 Anti Infectives 39 analyst Nick Batram 39 Dynepo TM 39 Paxil antidepressant 39 antidepressant Remeron 39 PharmaVitae Profile 39 Williams de Broë 39 Johannes Thormann 39 Yasuo Ueki 39 Mark Bronzo managing 39 Isaac Ro 39 Jed Dorsheimer 39 GlaxoSmithKline PLC GSK.LN 39 Angelos Anastasiou 39 Eli Lilly nyse LLY 39 Swiss brokerage Helvea 39 Yogesh Radke 39 Janardan Menon 39 Partnering Guide 39 Serono SRA 39 Acambis ACAM 39 Dhulsini de Zoysa 39 Tim Linacre 39 Seiji Shiraishi chief 39 strategist Teun Draaisma 39 Ursodiol 39 analyst Fabian Smeets 39 pharmas 39 Fortify Source 39 Matthew Borsch 39 See Tex. Gov't 39 Plc SHP LN 39 Steven Dashevsky head 39 Mikir Shah 39 ROG.VX Quote Profile Research 39 Mabthera 39 Anindya Mohinta 39 LSE PFZ 39 Helena Nordman Knutson 39 George Vasic strategist 39 Orchid Chem 39 John Buonaccorsi 39 analyst Liana Moussatos 39 Schering Plough nyse SGP 39 GlaxoSmithkline 39 Lipoxen 39 stockbroker Seymour Pierce 39 SHK Research 39 Leon Esterhuizen 39 velaglucerase 39 GlaxoSmithKline Plc GSK LN 39 analyst Martijn den 39 Larry Biegelsen 39 economist Akira Maekawa 39 Matrix Labs 39 Christophe Menard 39 Grofik 39 Taunya Sell 39 Gilad Alper 39 Generics 39 Quynh Pham 39 Seamus Fernandez 39 Novo Nordisk NOVOb.CO 39 AstraZeneca Plc 39 Holger Blum 39 Biopharm Development 39 SEDOL # GICS 39 biosimilar versions 39 rEV# 39 ADR NASDAQ TEVA 39 analyst Georg Kanders 39 Marco Gulpers 39 Richard Withagen 39 Novartis AG generics 39 David Amsellem 39 analyst Bert Hazlett 39 Amgen Prolia 39 Jean Philippe Bertschy 39 stockbroker Hargreaves Lansdown 39 Tang Yonggang 39 Tocosol 38 Majed Azzam 38 Tesofensine 38 Jeff Bradacs senior 38 analyst Ross Muken 38 LSE EDA 38 Switzerland Serono SA 38 Sonam Udasi 38 Roche RHHBY 38 Stacy Rasgon 38 Anidulafungin 38 Michael Shillaker 38 Irene Himona 38 Suresh Mahadevan 38 Willem Sels 38 analyst Mark Monane 38 Dominic O'Kane 38 Raghu Hariharan 38 analyst Dirk Peeters 38 Hargreaves Lansdown stockbrokers 38 Yasuhiro Nakazawa 38 Sasfin Frankel Pollak 38 analyst Victor Bareno 38 analyst Joanne Wuensch 38 Elisabeth Denison 38 Claudia Shank Hueston 38 ICAP Patent 38 Kotak Institutional 38 Sydbank analyst Rune Dahl 38 COLAL PRED 38 Shanta Biotech 38 Zheng Weigang 38 Greger Johansson 38 generic Lovenox 38 Pfizer PFE.N 38 Georg Kanders 38 looming patent expiries 38 Dynepo 38 Seattle Genetics SGEN 38 Antisoma 38 Ciaran Barr 38 MRK.N 38 KBC Peel Hunt 38 Amylin Alkermes 38 John DiFucci 38 Oncogenex 38 Matthew McEachran analyst 38 Anchen Pharmaceuticals 38 Petercam 38 Tramadol Ultram 38 PLAVIX ® 38 Savanth Sebastian 38 Olivia Frieser 38 broker Numis 38 readacross 38 Joulferon 38 Patent expiries 38 GlaxoSmithKline GSK.L 行情 38 analyst Amrita Sen 38 CFC Seymour Ltd. 38 Elan Tysabri 38 Dolmen Securities 38 Satish Betadpur 38 Religare Hichens Harrison 38 Newsflow 38 analyst Randall Stanicky 38 Li Xianming 38 Smithkline 38 Pranav Mer 38 Nexium ulcer drug 38 Peter Olofsen 38 Vioxx Zocor 38 Singer Capital Markets 38 Acambis Plc 38 Sarabjit Kour Nangra 38 Genentech DNA.N Quote Profile 38 analyst Amit Hazan 38 Helvea SA 38 Allergy Therapeutics 38 Nigel Brooksby 38 George Staphos 38 analyst Geoff Zame 38 Barry Labinger 38 Eric Coldwell 38 #-#.# mln [002] 38 AstraZenica 38 Astex Therapeutics 38 Zhejiang Tianyuan Bio 38 PHARMACEUTICALS 38 Huw van Steenis 38 Gonal F 38 Muken 38 Phil Codling 38 Alexandre Le Drogoff 38 Evgeny Solovyov 38 Nana Otsuki 38 Underlying Parcels 38 strategist Henk Potts 38 broker Seymour Pierce 38 Member CIPF 38 Cobalt Pharmaceuticals 38 antibiotic Rocephin 38 Khuram Chaudhry 38 Elan ELN 38 Luuk van Beek 38 Kogenate 38 Lorna Tilbian 38 anlayst 38 biggest faller shedding 38 Jeff Wlodarczak 38 Tony Clapsis 38 Nikolaas Faes 38 analyst Christophe Barret 38 Mingchun Sun 38 Olivia Ker 38 analyst Junaid Husain 38 Tony Lesiak 38 stockbrokers Brewin Dolphin 38 LAF# 38 Berwin Leighton Paisner 38 analyst Elemer Piros 38 Ehrenkrantz King Nussbaum 38 Olive Xia 38 Marco Strittmatter 38 Protherics 38 Genzyme nasdaq GENZ 38 Stada Arzneimittel 38 analyst Fabrizio Croce 38 Plethora Solutions 38 Greg Feehely 38 Criminal Procedure CrPC 38 economist George Tharenou 38 Viktor Dammann 38 Jon Balkind 38 Pronova 38 Michael Kovacocy 38 Phil Nalbone 38 cholesterol reducer Crestor 38 Royalblue 38 Investec Securities 38 Dainippon Sumitomo 38 Zegerid OTC 38 blood thinner Lovenox 38 Joanne Wuensch 38 analyst Deane Dray 38 Novartis Prexige 38 Ambrisentan 38 distributor Alliance UniChem 38 Yolande Barnes 38 Peter Rozenberg 38 Rob Bamforth principal 38 Susan Katzke 38 Laith Khalaf pensions 38 behind OUT LAW.COM 38 Steven Dashevsky 38 Ernie Hon 38 SEB Enskilda 38 Mike Lenhoff chief 38 Co LLY.N 38 analyst Robyn Karnauskas 38 analyst Lawrence Keusch 38 Par Pharma 38 Glenn Reicin 38 Impax Laboratories IPXL 38 Reiterate Outperform rating 38 HCl capsules 38 Henk Potts equity 38 Doxycycline Tablets 38 DPP4 38 bosutinib 38 Erik Suppiger 38 Replagal TM 38 Verona Pharma 38 Cailey Barker 38 Metabolic Pharmaceuticals 38 Roche ROG.VX Quote Profile 38 Immupharma 38 analyst Robert Campagnino 38 Schering Plough SGP.N 38 Microsoft Proofpoint Secure 38 Gidley Kitchin 38 Didier Scemama 38 Ryland Presentation 38 biotherapeutic drugs 38 Aveva 38 Biocompatibles 38 Junko Nishioka 38 Kepler Equities analyst 38 Damian McNeela 38 Jens Nordvig currency 38 Jeremy Batstone 38 NEVILLE CHESTER 38 Simos Simeonidis 38 Novartis NOVN.VX Quote Profile 38 Ramona Tipnis 38 Konrad Becker 38 Zocor Zetia 38 Cozaar Hyzaar 38 LSE IMT 38 Burdett Buckeridge Young 38 Pong Teng Siew 38 Biogen multiple sclerosis 38 Cadila Healthcare 38 Amlodipine Besylate 38 analyst Dirk Saelens 38 Jacob Bosscha 38 adjuvant colon cancer 38 GSK.L Quote Profile Research 38 analyst Cusson Leung 38 analyst Jonathan Geurkink 38 GLP 1s 38 Ong Choon Fah 38 Vertex VRTX 38 biogeneric 38 Rob Montefusco trader 38 Robert Heberger 38 AstraZeneca 38 analyst Shinichi Ina 38 analyst Greg Feehely 38 Acambis PLC 38 Bansei Securities 38 BMY.N 38 Teva Nasdaq TEVA 38 Simponi golimumab 38 James Grzinic 38 COX 2s 38 BLP# 38 Antony Broadbent 38 analyst Matthew McEachran 37 Marketweight 37 Actelion ATLN.VX 37 Analyst Steve Brozak 37 analyst Michael Kovacocy 37 Hugh Guy Lorriman 37 Lifecycle Pharma 37 Kazaka Commodity Co. 37 Henrik Gullberg 37 Manibhandu 37 Wyeth Enbrel 37 GSK '# 37 reinitiated coverage 37 gets USFDA nod 37 Plavix patent 37 Erkki Vesola 37 Cephalon Nasdaq CEPH 37 FW Holst 37 Eiji Maeda 37 Mirabaud Securities 37 Mamoru Maeda Chuo 37 Exanta 37 Tilbian 37 Januvia sitagliptin 37 analyst Hari Sambasivam 37 Sareum Holdings 37 Canvaxin 37 Matthew Heimermann 37 Ton van Ooijen 37 ZAE# JSE 37 CeNeS 37 Velaglucerase alfa 37 Liisa Bayko 37 broker Brewin Dolphin 37 GeneMedix 37 RBC Capital Mkts Reiterate 37 Paragraph IV Certification 37 Syncria 37 Nik Modi 37 Timothy Thein 37 alogliptin 37 strategist Peter Boockvar 37 glitazone 37 Teva Pharmaceutical TEVA 37 Daniel Meron 37 Ross Muken 37 Broker Panmure Gordon 37 AstraZenca 37 Hargreaves Lansdowne 37 analyst Alex Gauna 37 analyst Raj Denhoy 37 generic gabapentin 37 Ian de Verteuil 37 Mark Schappel 37 Glenmark Pharma 37 Panmure Gordon 37 Pierre Antony Vastra 37 Marc Leemans 37 Citalopram 37 Exane BNP Paribas 37 Zheng Weigang senior 37 Uche Orji 37 Walter De Wet 37 IG HCR ;) CO 37 Stiffel Nicolaus 37 analyst Frank Mitsch 37 Gaurav Dua head 37 Shire Pharmaceuticals SHPGY 37 Zhu Jianfang chief 37 Wiktor Bielski 37 Louis Miscioscia 37 Darko Mihelic 37 Gary Nachman 37 Bob Drbul 37 spokeswoman Nancy Pekarek 37 Rupak Ghose 37 analyst Raghu Hariharan 37 analyst Victor Lazarovici 37 Koichi Nosaka market 37 Christian Bendixen 37 analyst Hideyuki Maekawa 37 Neurontin gabapentin 37 Daubert v. 37 Davy Stockbrokers 37 Hovnanian Enterprises Presentation 37 Beazer Homes Presentation 37 LSE BARC 37 Trovax 37 Nasdaq HGSI 37 Dave Rovelli 37 Celgene CELG 37 Seshadri Sen 37 Biota Relenza 37 Johan Eliason 37 AstraZeneca Brilinta 37 hypertension drugs Cozaar 37 Dr Chiplin 37 Maarten Bakker 37 analyst Charles Neivert 37 Antiflu 37 Piper Jaffray PJC 37 Toprol 37 Xenoport Inc. 37 analyst Lori Appelbaum 37 Arthro Kinetics 37 Commercial Leading Indicator 37 Biocryst 37 Penwest Pharma 37 ulcer pill 37 Bank Oyens 37 Matt Spick 37 ReNeuron 37 Plavix clopidogrel 37 analyst Mark Lipacis 37 Alain Tchibozo 37 Albert Ploegh 37 analyst Onno Rutten 37 Persimmon PSN.L Quote Profile 37 Fibrillex 37 Vanda Pharma 37 Elio Evangelista senior 37 FOR FURTHER INFORMATION ABOUT 37 Suneet Kamath 37 Glance STOCKS NEWS EUROPE 37 Molowa 37 Administrative Offenses 37 Kevin Lings 37 Jonathan Copus 37 Richard Kelertas 37 SHP LN 37 GlaxoSmithKline nyse 37 XenoPort XNPT 37 BROKERWATCH 37 Peter Sigley 37 Emkay Shares 37 Biogen Elan 37 Anders Trapp 37 UCB Keppra 37 analyst Nick Bubb 37 Merck Arcoxia 37 GLAXOSMITHKLINE 37 GlaxoSmith Kline 37 Georges Lequime 37 Ken Trbovich 37 Tao Levy 37 THALOMID R 37 Atrasentan 37 Brandgaard 37 flu vaccine Fluarix 37 Dushan Batrovic 37 Tom Troubridge 37 Peter Hemington partner 37 Asa Bridle 37 Sanofi Aventis Taxotere 37 Dana Saporta economist 37 Juvista 37 CeNeS Pharmaceuticals 37 Curagen 37 Lundbeck AS 37 Launches Generic Version 37 Robin Bhar metals 37 Suresh Balaraman 37 Cormark Securities 37 Chris Umiastowski 37 Novartis Gilenia 37 Kemp Dolliver 37 pharmeceutical 37 Casodex 37 ImmunoGen IMGN 37 Inc WPI.N 37 Jaap Meijer 37 solanezumab 37 economist Sunil Kapadia 37 Kian Abouhossein 37 Pfizer Norvasc 37 Pierre Ferragu 37 Tony Foggett 37 Richard Jerram economist 37 Brewin Dolphin 37 Hysan Development 37 Altium Securities analyst 37 Ana Gupte 37 Sam Buttrick 37 Christows 37 SAN FP 37 GSK Advair 37 Joost van Leenders 37 Wanguo Securities 37 analyst Les Funtleyder 37 Abbott Niaspan 37 MEDA AB publ 37 Rachael Waring 37 GlaxoSmithKline plc LON GSK 37 housebuilders Persimmon 37 Glenn Novarro 37 Gavin Redknap 37 GlaxoSmithKline 37 Premarin Prempro 37 Please visit www.antisoma.com 37 Mario Mendonca 37 reaffirmed Market Perform 37 analyst Geoffrey Porges 37 Wyeth nyse WYE 37 developer Biota Holdings 37 Vorapaxar 37 Oswald Clint 37 Bryan Piskorowski 37 David Hallden 37 Henrik Breum 37 Alembic HC Securities 37 firmed #.#p [002] 37 Cefzil 37 Saquinavir 37 analyst Herman Saftlas 37 Arden Partners 37 Merck KGaA MRK GY 37 Cusson Leung 37 Kuni Chen 37 Sawai Pharmaceutical 37 Ed Teather 37 Seema Shah 37 Francis Campeau broker 37 code FI# Minimum 37 pioglitazone hydrochloride 37 pharma 37 NOVN.VX Quote Profile Research 37 Joe Liro equity 37 CytoFabTM 37 Minster Pharmaceuticals 37 CapitaLand Keppel Land 37 Arbuthnot Securities 37 Sandoz Novartis 37 analyst Glenn Schorr 37 #-# vphl Norwegian 37 Raj Denhoy 37 economist Shamubeel Eaqub 37 economist Dana Saporta 37 analyst Lakis Athanasiou 37 Brent Thill 37 Pravachol cholesterol 37 AG NOVN.VX Quote Profile 37 Prolor 37 About DonHarrold.net DonHarrold.net 37 GlaxoSmithKline Plc 37 Rheumatoid Arthritis Drug 37 Emilie Mazzacurati 37 Novartis AG Foradil 37 Klaus Linde 37 Risperdal schizophrenia drug 37 ValiRx 37 Drugmaker AstraZeneca 37 Bifeprunox 37 Mumbai Angel Broking 37 analyst Lizabeth Dunn 37 Gabapentin 37 Glenmark Pharmaceutical 37 Schizophrenia Drug 37 Eisai Aricept